CALCIUM INFUSION FOR REVERSAL OF ADVERSE-EFFECTS OF INTRAVENOUS VERAPAMIL

被引：26

作者：

MORRIS, DL

GOLDSCHLAGER, N

机构：

[1] SAN FRANCISCO GEN HOSP,MED CTR,CARDIOL SERV,SAN FRANCISCO,CA 94110

[2] SAN FRANCISCO GEN HOSP,MED CTR,MED SERV,SAN FRANCISCO,CA 94110

[3] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1983年 / 249卷 / 23期

关键词：

D O I：

10.1001/jama.249.23.3212

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3212 / 3213

页数：2

共 15 条

[11] HEMODYNAMIC CONSEQUENCES OF COMBINED BETA-ADRENERGIC AND SLOW CALCIUM-CHANNEL BLOCKADE IN MAN [J].

PACKER, M ;

MELLER, J ;

MEDINA, N ;

YUSHAK, M ;

SMITH, H ;

HOLT, J ;

GUERERRO, J ;

TODD, GD ;

MCALLISTER, RG ;

GORLIN, R .

CIRCULATION, 1982, 65 (04) :660-668

[12] SERIOUS VERAPAMIL POISONING - TREATMENT WITH INTRAVENOUS CALCIUM GLUCONATE [J].

PERKINS, CM .

BRITISH MEDICAL JOURNAL, 1978, 2 (6145) :1127-1127

[13] VERAPAMIL THERAPY - A NEW APPROACH TO THE PHARMACOLOGIC TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY .3. EFFECTS OF LONG-TERM ADMINISTRATION [J].

ROSING, DR ;

CONDIT, JR ;

MARON, BJ ;

KENT, KM ;

LEON, MB ;

BONOW, RO ;

LIPSON, LC ;

EPSTEIN, SE .

AMERICAN JOURNAL OF CARDIOLOGY, 1981, 48 (03) :545-553

[14] VERAPAMIL THERAPY - NEW APPROACH TO THE PHARMACOLOGIC TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY .1. HEMODYNAMIC-EFFECTS [J].

ROSING, DR ;

KENT, KM ;

BORER, JS ;

SEIDES, SF ;

MARON, BJ ;

EPSTEIN, SE .

CIRCULATION, 1979, 60 (06) :1201-1207

[15] VERAPAMIL THERAPY - NEW APPROACH TO THE PHARMACOLOGIC TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY .2. EFFECTS ON EXERCISE CAPACITY AND SYMPTOMATIC STATUS [J].

ROSING, DR ;

KENT, KM ;

MARON, BJ ;

EPSTEIN, SE .

CIRCULATION, 1979, 60 (06) :1208-1213

← 1 2 →